Patterns of clinical presentation of climacteric syndrome and total body composition in women with menopausal metabolic syndrome

Introduction. Modern gynecological endocrinology widely discusses various disorders accompanying the onset of menopause. Metabolic disorders are one of the leading risk factors for the development of ischemic heart disease and vascular dystonia in menopausal women. That is why the drugs prescribed a...

Full description

Saved in:
Bibliographic Details
Published in:Medicinskij sovet no. 13; pp. 170 - 175
Main Authors: Shulukian, Z. E., Tselkovich, L. S., Balter, R. B., Ivanova, T. V., Ibragimova, A. R., Hamadianova, A. U., Ilchenko, O. A.
Format: Journal Article
Language:English
Russian
Published: Remedium Group LLC 16-10-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction. Modern gynecological endocrinology widely discusses various disorders accompanying the onset of menopause. Metabolic disorders are one of the leading risk factors for the development of ischemic heart disease and vascular dystonia in menopausal women. That is why the drugs prescribed as part of menopausal hormone therapy are contraindicated for patients with severe metabolic disorders and predisposition to thrombosis. Women with a normal body mass index may develop the menopausal metabolic syndrome, since its presentations largely depend on the total body composition and the specific gravity of visceral adipose tissue. Aim. To assess the patterns of clinical presentation of menopause in women with metabolic menopausal syndrome. Materials and methods. In the furtherance of that aim, we examined 184 women who were in menopause 1 to 5 years at the age of 52 to 57 years (average age 54.2 ± 0.5 years). Of these, 87 were diagnosed with metabolic syndrome – they were included in the main group. The comparison group included 97 menopausal women without metabolic disorders. Results and discussion. We assessed the severity of clinical presentations and the total body composition of the patients in the selected groups. It has been established that the body mass index cannot serve as a criterion for evaluation of metabolic processes, despite the sufficient simplicity of its computation. Conclusions. The authentic view of the risks of metabolic disorders in menopausal women requires the study of total body composition.
ISSN:2079-701X
2658-5790
DOI:10.21518/2079-701X-2021-13-170-175